Two Sigma Securities’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Two Sigma Securities’s Portfolio CSCI Stock Details CSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,981	Closed	-$29.8K	–	3702
2023 Q3	$29.8K	Buy	+2,981	New	+$33.1K	﹤0.01%	2525
2022 Q3	–	Sell	-400	Closed	-$8K	–	3202
2022 Q2	$8K	Buy	+400	New	+$10K	﹤0.01%	2078
2021 Q2	–	Sell	-246	Closed	-$28K	–	1761
2021 Q1	$28K	Buy	+246	New	+$27.3K	﹤0.01%	764
2020 Q2	–	Sell	-110	Closed	-$6K	–	1823
2020 Q1	$6K	Buy	+110	New	+$10K	﹤0.01%	1258
2018 Q1	–	Sell	-163	Closed	-$39K	–	3008
2017 Q4	$39K	Sell	163 -103	-39%	-$21.4K	﹤0.01%	1564
2017 Q3	$54K	Sell	266 -222	-45%	-$40.9K	﹤0.01%	735
2017 Q2	$49K	Buy	+488	New	+$77.3K	0.01%	725
2015 Q4	–	Sell	-6	Closed	-$5K	–	388
2015 Q3	$5K	Buy	+6	New	+$8.73K	0.01%	204
2015 Q2	–	Sell	-3	Closed	-$18K	–	282
2015 Q1	$18K	Hold	3	–	–	0.02%	180
2014 Q4	$16K	Buy	+3	New	+$25.2K	0.01%	237

Other funds holding CSCI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

EDRH

Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Two Sigma Securities's CSCI Position: Q4 2023 in Review

Two Sigma Securities sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q4 2023, closing a stake of 2,981 shares — an estimated $29.8K sold.

Two Sigma Securities first reported a position in CSCI in Q4 2014 and held it in 10 quarters. The position peaked at $54K in Q3 2017. 12 funds tracked by Wall St. Rank hold CSCI as of Q4 2023.

Two Sigma Securities reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Two Sigma Securities sold 2,981 COSCIENS Biopharma Inc. Common Stock shares in Q4 2023, an estimated $29.8K.
Two Sigma Securities first reported a position in COSCIENS Biopharma Inc. Common Stock in Q4 2014 and held it in 10 quarters.
Two Sigma Securities's COSCIENS Biopharma Inc. Common Stock position peaked at $54K in Q3 2017.
12 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q4 2023.

Based on Two Sigma Securities's 13F filing for Q4 2023, filed 14 Feb 2024.